TG Therapeutics ($TGTX) Insider Trading & Smart Money Activity

TG Therapeutics, Inc. · Biotechnology · Latest filing Jun 11, 2026

TG Therapeutics, Inc. ($TGTX) has 1 insider trade on file. Insiders filed 1 Form 4 transaction in the last 12 months, none of them open-market purchases or sales.

Insider buyers (12 mo): 0
Insider sellers (12 mo): 0
Net insider $ (12 mo): $0
Congress trades (12 mo): 0
13F moves on file: 0
Analyst ratings on file: 0

TGTX insider buying and selling by quarter

Quarter	Congress buys / sales	13F added / cut
Q1 2026	0 / 0	0 / 0
Q2 2026	0 / 0	0 / 0
Q3 2026	0 / 0	0 / 0
Q4 2026	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All TGTX insider, congress, 13F and analyst activity

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Jun 11, 2026	Insider	Daniel Hume	Buy (Grant or award)	8.32K sh			+10.8%	+14.5%			Read

1W / 1M / 6M = how TGTX moved from the trade or filing date.

Insider trading in TGTX: who is buying and selling

Insider	Role	Trades	Open-market net	Shares held	Last trade
Daniel Hume		1	—		Jun 11, 2026

Frequently asked questions

What is the latest insider trade in TGTX?

Daniel Hume filed a buy (grant or award) of 8.32K sh on Jun 11, 2026.

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text